Document:

Exhibit 10.3

 

indemnification
agreement

 

THIS INDEMNIFICATION AGREEMENT (the
“Agreement”), dated as of ____, 201_, is entered into by and between Kornit Digital Ltd., an Israeli
company whose address is 12 Ha-Amal Street, Rosh Ha-Ayin, Israel (the “Company”), and the director or officer
of the Company whose name appears on the signature page hereto (the “Indemnitee”).

 

		WHEREAS,	Indemnitee is an Office Holder (“Nosse Misra”),
as such term is defined in the Companies Law, 5759–1999, as amended (the “Companies
Law” and “Office Holder” respectively),
of the Company, and, at the request of the Company, may serve in the capacity of an Office Holder of a company controlled by the
Company; 

 

		WHEREAS,	both the Company and Indemnitee recognize the increased risk
of litigation and other claims being asserted against Office Holders of companies and that highly competent persons have become
more reluctant to serve corporations as directors and officers or in other capacities unless they are provided with adequate protection
through insurance or adequate indemnification against inordinate risks of claims and actions against them arising out of their
service to, and activities on behalf of, companies; 

 

		WHEREAS,	the Articles of Association
of the Company authorize the Company to indemnify and advance expenses to its Office Holders and provide for insurance and exculpation
to its Office Holders, in each case, to the fullest extent permitted by applicable law;

 

		WHEREAS,	the Company has determined that (i) the increased difficulty
in attracting and retaining competent persons is detrimental to the best interests of the Company’s shareholders and that
the Company should act to assure such persons that there will be increased certainty of such protection in the future, and (ii)
it is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, and to advance expenses
on behalf of, such persons to the fullest extent permitted by applicable law, so that they will serve or continue to serve the
Company directly or, at the Company’s request, through another entity controlled
by the Company, free from undue concern that they will not be so indemnified; and

 

		WHEREAS,	in recognition of Indemnitee’s need for substantial protection
against personal liability in order to assure Indemnitee’s continued service to the Company directly or, at the Company’s
request, through another entity controlled by the Company, in an effective manner and, in part, in order to provide Indemnitee
with specific contractual assurance that the indemnification, insurance and exculpation afforded by the Articles of Association
will be available to Indemnitee, the Company wishes to undertake in this Agreement for the indemnification of and the advancing
of expenses to Indemnitee to the fullest extent permitted by applicable law and as set forth in this Agreement and provide for
insurance and exculpation of Indemnitee as set forth in this Agreement.

 

NOW, THEREFORE, the parties hereto
agree as follows:

 

		1.	INDEMNIFICATION.

 

		1.1.	The Company hereby undertakes to indemnify Indemnitee to the fullest extent permitted by applicable
law for any liability and expense specified in Sections ‎1.1.1 through ‎1.1.4 below, imposed on Indemnitee due to or in
connection with an act performed by such Indemnitee, either prior to or after the date hereof, in Indemnitee’s capacity as
an Office Holder, including, without limitation, as a director, officer, employee, agent or fiduciary of the Company, any subsidiary
thereof or any another corporation, collaboration, partnership, joint venture, trust or other enterprise, in which Indemnitee serves
at any time at the request of the Company (the “Corporate Capacity”). The term “act performed in Indemnitee’s
capacity as an Office Holder” shall include, without limitation, any act, omission and failure to act and any other circumstances
relating to or arising from Indemnitee’s service in a Corporate Capacity. The following shall be hereinafter referred to
as “Indemnifiable Events”:

 

    	 

    	 

    

 

		1.1.1.	Financial liability imposed on Indemnitee in favor of any person pursuant to a judgment, including
a judgment rendered in the context of a settlement or an arbitrator’s award approved by a court.

 

		1.1.2.	Reasonable Expenses (as defined below) expended or incurred by Indemnitee (i) as a result of an
investigation or any proceeding instituted against the Indemnitee by an authority that is authorized to conduct an investigation
or proceeding, and that was concluded without filing an indictment against the Indemnitee and without imposing on the Indemnitee
a financial obligation in lieu of a criminal proceeding, or that was concluded without filing an indictment against the Indemnitee
but imposing a financial obligation in lieu of a criminal proceeding in an offence that does not require proof of mens rea,
or (ii) in connection with a financial sanction. In this section “conclusion of a proceeding without filing an indictment
in a matter in which a criminal investigation has been instigated” and “financial liability in lieu of a criminal proceeding”
shall have the meaning assigned to such terms under the Companies Law, and the term "financial sanction" shall mean such
term as referred to in Section 260(a)(1a) of the Companies Law;

 

		1.1.3.	Reasonable Expenses incurred by or charged to Indemnitee by a court, in a proceeding instituted
against him by the Company or on its behalf or by another person, or in a criminal charge from which he or she was acquitted or
in which he or she was convicted of an offence that does not require proof of Mens Rea; and

 

		1.1.4.	Any other event, occurrence, matter or circumstances in respect of which the Company may, or will
be able to, indemnify an Office Holder of the Company (including, without limitation, under Section 56h(b)(1) of the Israeli Securities
Law 5728-1968 (the "Israeli Securities Law"), if applicable, and Section 50P(b)(2) of the Israeli Restrictive
Trade Practices Law, 5758-1988 (the “RTP Law”)).

 

For the purpose of this Agreement,
“Expenses” shall include, without limitation, attorneys’ fees and all other costs, expenses and obligations
paid or incurred by Indemnitee in connection with investigating, defending, being a witness in or participating in (including on
appeal), or preparing to defend, be a witness in or participate in any claim relating to any matter for which indemnification hereunder
may be provided. Expenses shall be considered paid or incurred by Indemnitee at such time as Indemnitee is required to pay or incur
such cost or expenses, including upon receipt of an invoice or payment demand. The Company shall pay the Expenses in accordance
with the provisions of Section ‎1.3.

 

    	- 2 -

    	 

    

 

		1.2.	Notwithstanding anything herein to the contrary, the Company’s undertaking to indemnify the
Indemnitee in advance under Section ‎1.1.1 shall only be in respect to events described in Exhibit A hereto (without
limitation of the Company's ability to indemnity retroactively, at its discretion and subject to applicable law). The Board of
Directors of the Company (the “Board”) has determined that the categories of events listed in Exhibit A are
likely to occur in light of the operations of the Company. The maximum amount of indemnification payable by the Company under Section
‎1.1.1 of this Agreement for each specific event of the categories described in Exhibit A and the aggregate amount of indemnification
for all events described in Exhibit A shall be as set forth in Exhibit A (the “Limit Amount”). The Limit Amount
payable by the Company as described in Exhibit A is deemed by the Company to be reasonable in light of the circumstances. The indemnification
provided under Section ‎1.1.1 herein shall not be subject to the limitations imposed by this Section ‎1.2 and Exhibit A
if and to the extent such limits are no longer required by the Companies Law.

 

		1.3.	To the fullest extent permitted by law, the Company will make available all amounts payable to
Indemnitee in accordance with Section 1 above on the date on which such amounts are first payable by Indemnitee. If so requested
by Indemnitee, and subject to the Company’s repayment and reimbursement rights set forth in Sections ‎3 and ‎5 below,
the Company shall advance payments to cover Indemnitee’s Expenses with respect to which Indemnitee is entitled to be indemnified
under Section ‎1.1 above. The payments of such amounts shall be made by the Company directly to the Indemnitee (if Indemnitee
actually made payment of such amount) or to the relevant third party (if Indemnitee has not yet made payment of such amount), as
soon as practicable, but in any event no later than fifteen (15) days after written demand by such Indemnitee therefor
to the Company, and any such payment shall be deemed to constitute indemnification hereunder. As part of the aforementioned undertaking,
the Company will make available to Indemnitee any security or guarantee that Indemnitee may be required to post in accordance with
an interim decision given by a court, governmental or administrative body, or an arbitrator, including for the purpose of substituting
liens imposed on Indemnitee’s assets.

 

		1.4.	The Company’s obligation to indemnify Indemnitee and advance Expenses in accordance with
this Agreement shall be for such period (the “Indemnification Period”) as Indemnitee shall be subject to any
actual, possible or threatened claim, action, suit, demand or proceeding or any inquiry or investigation, whether civil, criminal
or investigative, arising out of the Indemnitee’s service in the Corporate Capacity as described in Section ‎1.1 above,
whether or not Indemnitee is still serving in such position.

 

		1.5.	The indemnification hereunder will, in each case, cover all sums of money (100%) that Indemnitee
will be obligated to pay, in those circumstances for which indemnification is required, and to the extent required, to be paid
under this Agreement.

 

		2.	SPECIFIC LIMITATIONS ON INDEMNIFICATION.

 

Notwithstanding anything
to the contrary in this Agreement, the Company shall not indemnify or advance Expenses to Indemnitee with respect to (i) any act,
event or circumstance with respect to which it is prohibited to do so under applicable law, or (ii) a counter claim made by the
Company or in its name in connection with a claim against the Company filed by the Indemnitee, other than a claim to enforce such
Indemnitee’s rights under this Agreement.

 

    	- 3 -

    	 

    

 

		3.	REPAYMENT OF EXPENSES.

 

		3.1.	In the event that the Company provides or is required to provide indemnification with respect to
Expenses hereunder and at any time thereafter the Company determines, based on advice from its legal counsel, that the Indemnitee
was not entitled to such payments, the amounts so indemnified by the Company will be promptly repaid by Indemnitee, unless the
Indemnitee disputes the Company’s determination, in which case the Indemnitee’s obligation to repay to the Company
shall be postponed until such dispute is resolved.

 

		3.2.	Indemnitee’s obligation to repay to the Company for any Expenses or other sums paid hereunder
shall be deemed as a loan given to Indemnitee by the Company subject to the minimum interest rate prescribed by Section 3(9) of
the Income Tax Ordinance [New Version], 1961, or any other legislation replacing it, which is not considered a taxable benefit.

 

		4.	SUBROGATION.

 

In the event of payment
under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee,
who shall execute all documents required and shall do everything that may be necessary to secure such rights, including the execution
of such documents necessary to enable the Company effectively to bring suit to enforce such rights.

 

		5.	PRIMACY OF INDEMNIFICATION; REIMBURSEMENT.

 

		5.1.	The Company hereby acknowledges that Indemnitee may have certain rights to indemnification, advancement
of expenses and/or insurance provided by the party nominating such Indemnitee to serve on the Board of Directors of the Company
or by affiliates of such party (the “Sponsor Indemnitors”). The Company hereby agrees (i) that it is the indemnitor
first resort (i.e., its obligations to Indemnitee are primary and any obligation of the Sponsor Indemnitors to advance expenses
or to provide indemnification for the same expenses or liabilities incurred by Indemnitee are secondary), (ii) that it shall be
required to advance the full amount of expenses incurred by Indemnitee and shall be liable for the full amount of all expenses,
judgments, penalties, fines and amounts paid in settlement to the extent legally permitted and as required by the terms of this
Agreement and the Articles of Association, without regard to any rights Indemnitee may have against the Sponsor Indemnitors, and,
(iii) that it irrevocably waives, relinquishes and releases the Sponsor Indemnitors from any and all claims against the Sponsor
Indemnitors for contribution, subrogation or any other recovery of any kind in respect thereof. The Company further agrees that
no advancement or payment by the Sponsor Indemnitors on behalf of Indemnitee with respect to any claim for which Indemnitee has
sought indemnification from the Company shall affect the foregoing and the Sponsor Indemnitors shall have a right of contribution
and/or be subrogated to the extent of such advancement or payment to all of the rights of recovery of Indemnitee against the Company.
The Company and Indemnitee agree that the Sponsor Indemnitors are express third party beneficiaries of the terms of this Section
5.

 

		5.2.	Notwithstanding any other provision of this Agreement, to the extent that Indemnitee is a witness
or is required to (or asked to) respond to discovery requests in any proceeding involving the Company, any subsidiary thereof,
any another person in which Indemnitee serves at any time at the request of the Company, its officers or directors, in their Corporate
Capacities, to which Indemnitee is not a party, Indemnitee shall be indemnified against all expenses paid or incurred by Indemnitee
in connection therewith and in the manner set forth in this Agreement.

 

    	- 4 -

    	 

    

 

		5.3.	Subject to the provisions of this Section 5, the Company shall not be liable under this Agreement
to make any payment in connection with any Indemnifiable Event to the extent Indemnitee has otherwise actually received payment
under any insurance policy with respect to such Indemnifiable Event or otherwise (without any obligation of Indemnitee to repay
any such amount) of the amounts otherwise indemnifiable hereunder, but only to the extent of any such actually received payment.
Any amounts paid to Indemnitee under such insurance policy or otherwise after the Company has indemnified Indemnitee for such liability
or Expense shall be repaid to the Company promptly upon receipt by Indemnitee, in accordance with the terms set forth in Section‎3.1.

 

		6.	EFFECTIVENESS.

 

This Agreement shall be
valid, binding and enforceable in accordance with its terms and shall be in full force and effect immediately upon its approval
by the Company’s shareholders. If for the validation of any of the undertakings in this Agreement any corporate act, resolution,
approval or other procedure is required, the Company undertakes, to the extent permitted by law, to take all reasonable action
in order to cause them to be done or adopted in a manner which will enable the Company to fulfill all its undertakings as aforesaid.

 

		7.	NOTIFICATION AND DEFENSE OF CLAIM.

 

Indemnitee shall notify
the Company of the commencement of any action, suit or proceeding, and of the receipt of any notice or threat that any such legal
proceeding has been or shall or may be initiated against Indemnitee (including any proceedings by or against the Company and any
subsidiary thereof), promptly upon Indemnitee first becoming so aware; but the omission so to notify the Company will not relieve
the Company from any liability which it may have to Indemnitee under this Agreement unless and to the extent that such failure
to provide notice  prejudices the Company’s ability to defend such action. Notice to the Company shall be directed
to the Chief Executive Officer or Chief Financial Officer of the Company at the address shown in the preamble to this Agreement
(or such other address as the Company shall designate in writing to Indemnitee). With respect to any such action, suit or proceeding
as to which Indemnitee notifies the Company of the commencement thereof and without derogating from Sections ‎1.1 and ‎2:

 

		7.1.	The Company will be entitled to participate therein at its own expense.

 

		7.2.	Except as otherwise provided below, and other than with respect to proceedings that have been initiated
against Indemnitee by the Company or in its name, the Company, alone or jointly with any other indemnifying party similarly notified,
will be entitled to assume the defense thereof, with counsel selected by the Company, and reasonably satisfactory to the Indemnitee.
Indemnitee shall have the right to employ his or her own counsel in such action, suit or proceeding, but the fees and expenses
of such counsel incurred after notice from the Company of its assumption of the defense thereof shall be at the expense of Indemnitee,
unless: (i) the employment of counsel by Indemnitee has been authorized in writing by the Company; (ii) the Company shall
not have assumed the conduct of Indemnitee’s defense as contemplated in a timely manner, (iii) the Company refers the conduct
of Indemnitee’s defense to an attorney who is not reasonably satisfactory to the Indemnitee, (iv) the Indemnitee and the
Company shall have agreed (on the basis of advise by legal counsel) that there is a conflict of interest between the Company and
the Indemnitee in the conduct of the defense of such action; in either of which cases the reasonable fees and expenses of counsel
shall be at the expense of the Company. The Company shall not be entitled to assume the defense of any action, suit or proceeding
brought by or on behalf of the Company or as to which the Indemnitee and the Company shall have reached the conclusion specified
in (iv) above.

 

    	- 5 -

    	 

    

 

		7.3.	The Company shall not be liable to indemnify Indemnitee under this Agreement for any amounts or
expenses paid in connection with a settlement of any action, claim or otherwise, effected without the Company’s prior written
consent.

 

		7.4.	The Company shall have the right to conduct the defense as it sees fit in its sole discretion (provided
that the Company shall conduct the defense in good faith and in a diligent manner), including the right to settle or compromise
any claim or to consent to the entry of any judgment against Indemnitee without the consent of the Indemnitee, provided that, the
amount of such settlement, compromise or judgment does not exceed the Limit Amount (if applicable) and is fully indemnifiable pursuant
to this Agreement and/or applicable law, and any such settlement, compromise or judgment does not impose any penalty or limitation
on Indemnitee without the Indemnitee’s prior written consent. The Indemnitee’s consent shall not be required if the
settlement includes a complete release of Indemnitee, does not contain any admission of wrong-doing by Indemnitee, and includes
monetary sanctions only as provided above. In the case of criminal proceedings the Company and/or its legal counsel will not have
the right to plead guilty or agree to a plea-bargain in the Indemnitee’s name without the Indemnitee’s prior written
consent. Neither the Company nor Indemnitee will unreasonably withhold or delay their consent to any proposed settlement. The Company
shall not, without Indemnitee’s prior written consent, consent to the entry of any judgment against Indemnitee or enter into
any settlement or compromise which (i) includes an admission of Indemnitee’s fault, (ii) does not include, as an unconditional
term thereof, the full release of Indemnitee from all liability in respect of such proceeding or (iii) is not fully indemnifiable
pursuant to this Indemnification Agreement, any available insurance coverage and pursuant to law.

 

		7.5.	Indemnitee shall fully cooperate with the Company and shall give the Company all information and
access to documents, files and to his or her advisors and representatives as shall be within Indemnitee’s power, in every
reasonable way as may be required by the Company with respect to any claim which is the subject matter of this Agreement and in
the defense of other claims asserted against the Company (other than claims asserted by Indemnitee), provided that the Company
shall cover all expenses, costs and fees incidental thereto such that the Indemnitee will not be required to pay or bear such expenses,
costs and fees.

 

		7.6.	If the Company fails to comply with any of its material obligations under this Agreement or in
the event that the Company or any other person takes any action to declare this Agreement void or unenforceable, or institutes
any action, suit or proceeding to deny or to recover from Indemnitee the benefits intended to be provided to Indemnitee hereunder,
except with respect to such actions, suits or proceedings brought by the Company that are resolved in favor of the Company, Indemnitee
shall have the right to retain counsel of Indemnitee’s choice, and reasonably acceptable to the Company and at the expense
of the Company, to represent Indemnitee in connection with any such matter, to the extent that such matter is within the provisions
of Section 1 hereof.

 

    	- 6 -

    	 

    

 

		8.	EXCULPATION.

 

Subject to the provisions
of the Companies Law, the Company hereby releases, in advance, the Office Holder from liability to the Company for any damage that
arises from the breach of the Office Holder’s duty of care to the Company (within the meaning of such terms under Sections
252 and 253 of the Companies Law), other than breach of the duty of care towards the Company in a distribution (as such term is
defined in the Companies Law).

 

		9.	NON-EXCLUSIVITY.

 

The rights of the Indemnitee
hereunder shall not be deemed exclusive of any other rights Indemnitee may have under the Company’s Articles of Association,
applicable law, any agreement, a vote of shareholders or a resolution of directors, or otherwise. No amendment, alteration or repeal
of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee under this Agreement in respect of
any action taken or omitted by such Indemnitee prior to such amendment, alteration or repeal. No right or remedy herein conferred
is intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition
to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or
employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other
right or remedy. It is hereby clarified that nothing in here shall limit the Company’s right to indemnify the Indemnitee,
post factum, for any and all amounts or events, subject to applicable law.

 

		10.	PARTIAL INDEMNIFICATION.

 

If Indemnitee is entitled
under any provision of this Agreement to indemnification by the Company for some or a portion of the expenses, judgments, fines
or penalties actually or reasonably incurred by Indemnitee in connection with any proceedings, and not for the total amount thereof,
the Company shall nevertheless indemnify Indemnitee for the portion of such expenses, judgments, fines or penalties to which Indemnitee
is entitled under any provision of this Agreement. Subject to the provisions of Section ‎5 above, any amount received by Indemnitee
(under any insurance policy or otherwise) shall not reduce the Limit Amount hereunder and shall not derogate from the Company’s
obligation to indemnify the Indemnitee in accordance with the provisions of this Agreement up to the Limit Amount, as set forth
in Section ‎1.2.

 

		11.	BINDING EFFECT.

 

This Agreement shall be
binding upon and inure to the benefit of and be enforceable by the parties hereto and their respective successors and permitted
assigns. In the event of a merger or consolidation of the Company or a transfer or disposition of all or substantially all of the
business or assets of the Company, the Indemnitee shall be entitled to the same indemnification and insurance provisions as the
most favorable indemnification and insurance provisions afforded to the then-serving Office Holders of the Company, to the full
extent permitted by law. In the event that in connection with such transaction the Company purchases a directors and officers’
“tail” or “run-off” policy for the benefit of its then serving Office Holders, then such policy shall cover
Indemnitee and such coverage shall be deemed to be in satisfaction of the insurance requirements under this Agreement. This Agreement
shall continue in effect during the Indemnification Period regardless of whether Indemnitee continues to serve in a Corporate Capacity.

 

Any amendment to the Companies
Law, the Israeli Securities Law, the RTP Law or other applicable law adversely affecting the right of the Indemnitee to be indemnified
pursuant hereto shall be prospective in effect, and shall not affect the Company’s obligation or ability to indemnify the
Indemnitee for any act or omission occurring prior to such amendment, unless otherwise provided by applicable law.

 

    	- 7 -

    	 

    

 

		12.	SEVERABILITY.

 

The provisions of this Agreement
shall be deemed severable and the invalidity or unenforceability of any provision shall not affect the validity or enforceability
of the other provisions hereof. If any provision of this Agreement, or the application thereof or any circumstance, is invalid
or unenforceable, (a) a suitable and equitable provision shall be substituted therefor in order to carry out, so far as may be
valid and enforceable, the intent and purpose of such invalid or unenforceable provision and (b) the remainder of this Agreement
and the application of such provision or circumstances shall not be affected by such invalidity or unenforceability, nor shall
such invalidity or unenforceability affect the validity or enforceability of such provision, or the application thereof, in any
other jurisdiction.

 

		13.	NOTICE.

 

All notices and other communications
pursuant to this Agreement shall be in writing and shall be deemed provided if delivered personally, sent by facsimile, reputable
overnight courier or mailed by registered or certified mail (return receipt requested), postage prepaid, to the parties at the
addresses shown in the preamble to this Agreement, or to such other address as the party to whom notice is to be given may have
furnished to the other party hereto in writing in accordance herewith. Any such notice or communication shall be deemed to have
been delivered and received (i) in the case of personal delivery, on the date of such delivery, (ii) in the case of facsimile,
one business day after the date of transmission if electronic confirmation of full transmission is received, (iii) in the case
of a reputable overnight courier, three business days after deposit with such reputable overnight courier service, and (iv) in
the case of mailing, on the seventh business day following that on which the mail containing such communication is posted.

 

		14.	GOVERNING LAW; JURISDICTION.

 

This Agreement shall be
governed by and construed and enforced in accordance with the laws of the State of Israel, without giving effect to the conflicts
of law provisions of those laws. The Company and Indemnitee each hereby irrevocably consent to the jurisdiction and venue of the
courts of Tel Aviv, Israel for all purposes in connection with any action or proceeding which arises out of or relates to this
Agreement.

 

		15.	ENTIRE AGREEMENT.

 

This Agreement represents
the entire agreement between the parties and supersedes and replaces any other agreements, contracts or understandings between
the parties, whether written or oral, with respect to the subject matter of this Agreement[for Directors add:], including
without limitation that certain Indemnification Agreement previously signed between the parties.

 

Notwithstanding
the foregoing, the indemnification obligation set forth in this Agreement will also apply, subject to the terms, conditions and
limitations set forth in this Agreement, with respect to actions committed, in Indemnitee’s capacity as an Office Holder
of the Company or of any Affiliate, during the period prior to the date of this Agreement.

 

		16.	ADVERSE PRESUMPTION.

 

Neither the settlement nor
termination of any proceeding nor the failure of the Company to award indemnification or to determine that indemnification is payable
shall create an adverse presumption that Indemnitee is not entitled to indemnification hereunder. In addition, the termination
of any proceeding by judgment or order (unless such judgment or order provides so specifically) or settlement, shall not create
a presumption that Indemnitee did not act in good faith and in a manner which Indemnitee reasonably believed to be in or not opposed
to the best interests of the Company or, with respect to any criminal action or proceeding, had reasonable cause to believe that
Indemnitee’s action was unlawful.

 

    	- 8 -

    	 

    

 

		17.	NO MODIFICATION AND NO WAIVER.

 

No supplement, modification
or amendment, termination or cancellation of this Agreement shall be binding unless executed in writing by both of the parties
hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions
hereof (whether or not similar) nor shall such waiver constitute a continuing waiver.

 

		18.	ASSIGNMENTS; NO THIRD PARTY RIGHTS.

 

Neither party hereto may
assign any of its rights or obligations hereunder except with the express prior written consent of the other party (except in the
case of a merger or consolidation of the Company or a transfer or disposition of all or substantially all of the business or assets
of the Company, but subject to Section ‎11). Other than with respect to Section 5 hereof, nothing herein shall be deemed
to create or imply an obligation for the benefit of a third party. Without limitation of the foregoing, nothing herein shall be
deemed to create any right of any insurer that provides directors and officers’ liability insurance, to claim, on behalf
of Indemnitee, any rights hereunder.

 

		19.	SUCCESSORS.

 

Notwithstanding anything
to the contrary herein, this Agreement shall continue for the benefit of Indemnitee’s heirs', personal representatives',
executors' and administrators' benefit after Indemnitee ceases to be an Office Holder of the Company.

 

		20.	INTERPRETATION; DEFINITIONS.

 

Unless
the context shall otherwise require: words in the singular shall also include the plural, and vice versa; any pronoun shall include
the corresponding masculine, feminine and neuter forms; the words “include”, “includes” and “including”
shall be deemed to be followed by the phrase “without limitation”; the words “herein”, “hereof”
and “hereunder” and words of similar import refer to this Agreement in its entirety and not to any part hereof; all
references herein to Sections or clauses shall be deemed references to Sections or clauses of this Agreement; any references to
any agreement or other instrument or law, statute or regulation are to it as amended, supplemented or restated, from time to time
(and, in the case of any law, to any successor provisions or re-enactment or modification thereof being in force at the time);
any reference to “law” shall include any supranational, national, federal, state, local, or foreign statute or law
and all rules and regulations promulgated thereunder; any reference to a “day” or a number of “days” (without
any explicit reference otherwise, such as to business days) shall be interpreted as a reference to a calendar day or number of
calendar days; reference to month or year means according to the Gregorian calendar; reference to a “company”,
“corporate body” or “entity” shall include a, partnership, firm, company, corporation, limited liability
company, association, joint venture, trust, unincorporated organization, estate, or a government municipality or any political,
governmental, regulatory or similar agency or body, and reference to a “person” shall mean any of the foregoing or
a natural person.

 

		21.	COUNTERPARTS.

 

This Agreement may be executed
in any number of counterparts, each of which shall be deemed an original and enforceable against the parties actually executing
such counterpart, and all of which together shall constitute one and the same instrument; it being understood that parties need
not sign the same counterpart. The exchange of an executed Agreement (in counterparts or otherwise) by facsimile or by electronic
delivery in pdf format shall be sufficient to bind the parties to the terms and conditions of this Agreement, as an original.

 

[SIGNATURE PAGE TO FOLLOW]

 

    	- 9 -

    	 

    

 

IN WITNESS WHEREOF,
the parties, each acting under due and proper authority, have executed this Indemnification Agreement as of the date first mentioned
above, in one or more counterparts.

 

	Kornit Digital Ltd.	 	 
	 

                                 By:
	 	 
	 

                                 Name and title:
	 	 
	 	 	 
	Indemnitee	 	 
	 	 	 
	Name:	 	 
	 

                                 Signature:
	 	 
	 

                                 Address:
	 	 
	 

                                 Telephone:
	 	 
	 

                                 Facsimile:
	 	 

 

    	- 10 -

    	 

    

 

EXHIBIT
A*

 

	 	CATEGORY OF INDEMNIFIABLE EVENT
	 	 
	1.	Claims in connection with labor relations, employment or consulting relationships with and/or by employees or consultants of the Company, and in connection with business relations between the Company and its employees, independent contractors, customers, suppliers, agents, and various service providers.
	 	 
	2.	Negotiations, execution, delivery and performance of agreements of any kind or nature, anti-competitive acts, acts of commercial wrongdoing, approval of corporate actions including the approval of the acts of the Company’s management, their guidance and their supervision, actions concerning the negotiation or approval of transactions with Office Holders or shareholders, including controlling persons and claims of failure to exercise business judgment and a reasonable level of proficiency, expertise and care with respect to the Company’s business.  
	 	 
	3.	Violation, infringement, misappropriation, dilution and other misuse of copyrights, patents, designs, trademarks, service marks, trade secrets and any other intellectual property rights, acts in connection with the registration, assertion or protection of rights to intellectual property and the defense of claims related to intellectual property, breach of confidentiality obligations, acts in regard of invasion of privacy including with respect to databases, acts in connection with slander and defamation, and claims in connection with publishing or providing any information or omission thereof, including any filings with any governmental authorities, whether or not required under any applicable laws.
	 	 
	4.	Violations of securities laws of any jurisdiction, including without limitation, claims under the U.S. Securities Act of 1933 or the U.S. Securities Exchange Act of 1934 or under the Israeli Securities Law, fraudulent disclosure claims, failure to comply with any securities authority or any stock exchange disclosure or other rules and any other claims relating to relationships with investors, debt holders, shareholders and the investment community and/or related to inadequate or improper disclosure to any of the foregoing; claims relating to or arising out of financing arrangements, any breach of financial covenants or other obligations towards lenders or debt holders of the Company, class actions, violations of laws requiring the Company to obtain regulatory and governmental licenses, permits and authorizations in any jurisdiction; actions taken in connection with the offer, issuance, purchase, holding or disposition of any type of securities of Company, including, without limitation, the grant of options to purchase any of the same or any offering of the Company’s securities to private investors or to the public, and listing of such securities, or the offer by the Company to purchase securities from the public or from private investors or other holders, and any undertakings, representations, warranties and other obligations related to any such offering, listing or offer or to the Company’s status as a public company or as an issuer of securities; any occurrences resulting from the Company’s public filings or omissions to make a public filing, delisting of shares, or buy-back of Company’s securities.

 

    	- 11 -

    	 

    

 

	5.	Liabilities arising in connection with any products or services developed, manufactured, distributed, rendered, sold, provided, licensed or marketed by the Company and/or any third party acting on its behalf, and any actions in connection with the manufacture, distribution, provision, sale, marketing, license or use of such products or services, including without limitation in connection with professional liability and product liability claims.
	 	 
	6.	The offering of securities by the Company to the public and/or to private investors or the offer by the Company to purchase securities from the public and/or from private investors or other holders pursuant to a prospectus, agreement, notice, report, tender and/or any other proceeding, whether in the United States, Israel or abroad.
	 	 
	7.	Events in connection with change in ownership, control or in the structure of the Company, its reorganization, dissolution, or any decision concerning any of the foregoing, including but not limited to, merger, sale or acquisition of assets or shares, division, change in capital; actions in connection with the purchase or sale of companies, legal entities, business, securities or assets, and the division or consolidation thereof, including without limitation, any Tender Offer, Forced Sale of Shares, Arrangement and Compromise (as such capitalized terms are defined in the Companies Law) or any reorganization, merger or consolidation of whatever kind or nature within the meaning of any law applicable to such claim or demand.     
	 	 
	8.	Any claim or demand made in connection with any transaction not in the ordinary course of business of the Company, including the sale, lease or purchase of any assets or business.
	 	 
	9.	Any claim or demand made by any third party suffering any personal injury and/or bodily injury or damage to business or personal property or any other type of damage through any act or omission attributed to the Company, or its directors, officers, employees, agents or other persons acting or allegedly acting on its behalf, including, without limitation, failure to make proper safety arrangements for the Company or its employees and liabilities arising from any accidental or continuous damage or harm to the Company’s employees, its contractors, its guests and visitors as a result of an accidental or continuous event, or employment conditions, permanent or temporary, in the Company’s facilities; any act or omission undertaken in negotiating, signing and performing an insurance policy or any claim relating to a failure to maintain appropriate insurance and/or adequate safety measures.
	 	 
	10.	Any claim or demand made directly or indirectly in connection with complete or partial failure, by the Company or its directors, officers and employees, to pay, report, keep applicable records or otherwise, of any foreign, federal, state, county, local, municipal or city taxes or other compulsory payments of any nature whatsoever, including, without limitation, income, sales, service, use, transfer, excise, value added, registration, severance, stamp, occupation, customs, duties, real property, personal property, capital stock, social security, unemployment, disability, payroll or employee withholding or other withholding, including any interest, penalty or addition thereto, whether disputed or not.

 

    	- 12 -

    	 

    

 

	11.	Any administrative, regulatory, judicial or civil actions orders,decrees, suits, demands, demand letters, directives, claims, liens, investigations, proceedings or notices of noncompliance or violation by any governmental entity or other person alleging potential responsibility or liability (including potential responsibility or liability for costs of enforcement investigation, cleanup, governmental response, removal or remediation, for natural resources damages, property damage, personal injuries or penalties or for contribution,  indemnification, cost recovery, compensation or injunctive relief) arising out of, based on or related to (a) the presence of, release, spill, emission, leaning, dumping, pouring, deposit, disposal, discharge, leaching or migration into the environment (each a “Release”) or threatened Release of, or exposure to, any hazardous, toxic, explosive or radioactive substances, wastes or other pollutants, including petroleum or petroleum distillates, asbestos or asbestos-containing material, polychlorinated biphenyls (“PCBs”) or PCB-containing materials or equipment, radon gas, infectious or medical wastes and all other substances or wastes of any nature regulated pursuant to any environmental law, at any location, whether or not owned, operated, leased or managed by the Company or any of its subsidiaries, or (b) circumstances forming the basis of any violation of any environmental law or environmental permit, license, registration or other authorization required under applicable environmental law.
	 	 
	12.	Any administrative, regulatory or judicial actions, orders, decrees, suits, demands, demand letters, directives, claims, liens, investigations, proceedings or notices of noncompliance or violation by any governmental entity or other person alleging the failure to comply with any statute, law, ordinance, rule, regulation, order or decree of any governmental entity applicable to the Company or any of its businesses, assets or operations, or the terms and conditions of any operating certificate or licensing agreement.
	 	 
	13.	Participation and/or non-participation at the Company’s Board meetings, bona fide expression of opinion and/or voting and/or abstention from voting at the Company’s Board meetings.
	 	 
	14.	Review and approval of the Company’s financial statements, including any action, consent or approval related to or arising from the foregoing, including, without limitations, execution of certificates for the benefit of third parties related to the financial statements.  
	 	 
	15.	Violation of laws, rules or regulations requiring the Company to obtain regulatory and governmental licenses, permits and authorizations or laws related to any governmental grants in any jurisdiction (including without limitation relating to export and encryption). 
	 	 
	16.	Resolutions and/or actions relating to investments in the Company and/or its subsidiaries and/or affiliated companies and/or the purchase and sale of assets, including the purchase or sale of companies and/or businesses, and/or investment in corporate or other entities and/or investments in traded and/or negotiable securities and/or any other form of investment.   
	 	 
	17.	Liabilities arising out of advertising, including misrepresentations regarding the Company's products or services and unlawful distribution of emails and/or unlawful or inappropriate uses of other means of mass communication.
	 	 
	18.	An announcement or statement, including a position taken or an opinion or representation made in good faith by the Office Holder in the course of his or her duties or in conjunction with his or her duties, whether in public or in private, including during a meeting of the Board of Directors of the Company or any of the committees thereof.
	 	 
	19.	Management of the Company’s bank accounts, including money management, foreign currency deposits, securities, loans and credit facilities, credit cards, bank guarantees, letters of credit, consultation agreements concerning investments including with portfolio managers, hedging transactions, options, futures, and the like.

 

    	- 13 -

    	 

    

 

	20.	Any actions taken pursuant to or in accordance with the policies and procedures of the Company, and any omission to act pursuant thereto or in accordance therewith, whether such policies and procedures are published or not; an act or omission undertaken in contradiction to the Company’s Articles of Association. 
	 	 
	21.	All actions, consents and approvals relating to a distribution of dividends, in cash or otherwise.
	 	 
	 	Aggregate Limit Amount for all events together

 

The Limit Amount per each specific event
within the categories of events listed in Sections 1-21 (inclusive) above is the Maximum Amount.

 

The “Maximum Amount”
shall mean the greater of:

 

(a)  twenty-five
percent (25%) of the Company’s total shareholders’ equity according to the Company’s most recent financial statements
as of the time of the actual payment of indemnification;

 

(b) US$ 30 million;
and

 

(c)  in connection
with or arising out of a public offering of the Company’s securities, the aggregate amount of proceeds from the sale by the
Company and/or any shareholder of Company’s securities in such offering.

 

		*	Any reference in this Exhibit A to the Company shall mean the Company and any entity in which the
Indemnitee serves in a Corporate Capacity, and where the context requires, also any subsidiaries or other affiliates of the Company.

 

    	- 14 -Exhibit 10.5

 

SPECTRA PRINTING

OEM SUPPLY AGREEMENT

 

“THIS OEM SUPPLY AGREEMENT (“Agreement”)
is made and entered into as of this 6th day of January, 2006 (“Effective Date”) by and between SPECTRA PRINTING, a
division of DIMATIX, INC. (“Spectra”), having a place of business at 109 Etna Road, Lebanon, New Hampshire 03766-1422,
a corporation organized under the laws of the State of Delaware, U.S.A., and Kornit Digital Ltd. (“Kornit”), also
referred to as “Customer” in the Schedules to this Agreement), having a place of business at 5 David Navon Street,
POB 8406, Moshav Magshimim 56910, Israel and organized under the laws of Israel, collectively the “Parties”.

 

WHEREAS Kornit wishes to procure certain
Spectra Products for integration with Kornit Product.

 

NOW THEREFORE, the Parties hereby agree
as follows:

 

		1.	DEFINITIONS

 

		1.1	“Affiliate” means any
                                         corporation, partnership, association, or other entity with respect to which a party,
                                         directly or indirectly through a subsidiary, has not less than a majority beneficial
                                         ownership, but only if that corporation, partnership, association, or other entity expressly
                                         agrees in writing to be bound by this Agreement, and only while that ownership relationship
                                         exists.

 

		1.2	“Kornit Product” means
                                         a digital printer, printing system or Print Engine, designed, manufactured or marketed
                                         by or on behalf of Kornit, on a retail, distribution or OEM sales basis, which incorporates
                                         one or more Printhead(s) that have been purchased from Spectra.

 

		1.3	“Certified Ink” means
                                         an Ink which has achieved certain standards and test results in accordance with the then
                                         current procedures defined by Spectra.

 

		1.4	“Hardware” means Printheads,
                                         printing assemblies and other ink jet devices supplied by Spectra to Kornit.

 

		1.5	“Ink” means printing
                                         inks and other materials, which are jetted by Printheads.

 

		1.6	“Print Engine” means
                                         a device comprised of: (i) components for moving and controlling the movement of the
                                         Printhead and print media, paper path, and ink supply components (collectively, the “Mechanism”);
                                         (ii) a Printhead; and (iii) a power supply, and covers.

 

		1.7	“Printhead” means a
                                         piezoelectric device with multiple jets that eject droplets of Ink on demand.

 

		1.8	“Products” means Hardware
                                         and Spectra Ink supplied by Spectra to Kornit.

 

*** Confidential treatment has been requested
for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated
as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.

 

    	1

    	 

    

 

		1.9	“Reserved Markets”
                                         means those fields and/or applications defined in Schedule 3.

 

		1.10	“Spectra Ink” means
                                         Ink manufactured by or on behalf of Spectra.

 

		1.11	“Term” means the period
                                         beginning on the Effective Date and ending on the date on which this Agreement terminates
                                         under Section 6,

 

*** Confidential treatment has been requested
for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated
as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.

 

    	2

    	 

    

 

SPECTRA PRINTING

OEM SUPPLY AGREEMENT

 

THIS OEM SUPPLY AGREEMENT (“Agreement”)
is made and entered into as of this 6th day of January, 2005 (“Effective Date”) by and between SPECTRA PRINTING, a
division of DIMATIX, INC. (“Spectra”), having a place of business at 109 Etna Road, Lebanon, New Hampshire 03766-1422,
a corporation organized under the laws of the State of Delaware, U.S.A., and Kornit Digital Ltd. (“Kornit”), also
referred to as “Customer” in the Schedules to this Agreement), having a place of business at 5 David Navon Street,
POB 8406, Moshav Magshimim 56910, Israel and organized under the laws of Israel, collectively the “Parties”.

 

WHEREAS Kornit wishes to procure certain
Spectra Products for integration with Kornit Product.

 

NOW THEREFORE, the Parties hereby agree
as follows:

 

		1.	DEFINITIONS

 

		1.1	“Affiliate” means
                                         any corporation, partnership, association, or other entity with respect to which a party,
                                         directly or indirectly through a subsidiary, has not less than a majority beneficial
                                         ownership, but only if that corporation, partnership, association, or other entity expressly
                                         agrees in writing to be bound by this Agreement, and only while that ownership relationship
                                         exists.

 

		1.2	“Kornit Product” means
                                         a digital printer, printing system or Print Engine, designed, manufactured or marketed
                                         by or on behalf of Kornit, on a retail, distribution or OEM sales basis, which incorporates
                                         one or more Printhead(s) that have been purchased from Spectra.

 

		1.3	“Certified Ink” means
                                         an Ink which has achieved certain standards and test results in accordance with the then
                                         current procedures defined by Spectra.

 

		1.4	“Hardware” means Printheads,
                                         printing assemblies and other ink jet devices supplied by Spectra to Kornit.

 

		1.5	“Ink” means printing
                                         inks and other materials, which are jetted by Printheads.

 

		1.6	“Print Engine” means
                                         a device comprised of: (i) components for moving and controlling the movement of the
                                         Printhead and print media, paper path, and ink supply components (collectively, the “Mechanism”);
                                         (ii) a Printhead; and (iii) a power supply and covers.

 

		1.7	“Printhead” means
                                         a piezoelectric device with multiple jets that eject droplets of Ink on demand.

 

		1.8	“Products” means Hardware
                                         and Spectra Ink supplied by Spectra to Kornit.

 

*** Confidential treatment has been requested
for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated
as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.

 

    	1

    	 

    

 

		1.9	“Reserved Markets”
                                         means those fields and/or applications defined in Schedule 3.

 

		1.10	“Spectra Ink” means
                                         Ink manufactured by or on behalf of Spectra.

 

		1.11	“Term” means the period
                                         beginning on the Effective Date and ending on the date on which this Agreement
                                         terminates under Section 6.

 

		2.	PRODUCT SUPPLY

 

		2.1	Kornit and Spectra agree that all
                                         Spectra Products will be supplied by Spectra to Kornit in accordance with the terms and
                                         conditions of this Agreement, including the Schedules.

 

		2.2	Schedule 1 sets forth the basic
                                         terms and conditions of sale for Spectra Products. In connection with the warranty terms
                                         in this Schedule 1:

 

2.2.1 NO OTHER WARRANTY IS EXPRESSED OR IMPLIED. SPECTRA
SPECIFICALLY DISCLAIMS ANY IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. DETERMINATION OF THE SUITABILITY OF THE PRODUCTS DESCRIBED ON THE FACE HEREOF: IS THE SOLE RESPONSIBILITY OF KORNIT AND
SPECTRA SHALL HAVE NO RESPONSIBILITY IN CONNECTION THEREWITH. KORNIT WARRANTS THAT KORNIT IS NOT: PURCHASING THE PRODUCTS FOR
PERSONAL, FAMILY OR HOUSEHOLD PURPOSES. THE REMEDIES PROVIDED HEREIN ARE KORNIT’S SOLE AND EXCLUSIVE REMEDIES. SPECTRA SHALL
NOT BE LIABLE FOR ANY INDIRECT, SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES (INCLUDING, WITHOUT LIMITATION, LOST PROFITS),
WHETHER BASED IN CONTRACT, TORT OR ANY OTHER LEGAL THEORY, OR FOR THE COST OF SUBSTITUTE GOODS.

 

		2.3	Schedule 2 sets forth the prices
                                         and any related special terms for Spectra Products. New or additional Spectra Products
                                         will be automatically incorporated into Schedule 2 by means of Kornit delivering a purchase
                                         order to Spectra and by Spectra’s acknowledgement and acceptance of (including
                                         any changes to) said purchase order.

 

		2.4	Kornit will pay to Spectra the
                                         royalties set forth in Schedule 2, subject to the terms and conditions thereof. Kornit
                                         will provide Spectra with a written report, no later than  30 (thirty) days following the end of
                                         each calendar quarter, describing for such  calendar quarter amount, type and price of all Ink sold, leased or otherwise
                                         disposed of, for use with Kornit Product during such period, together with a detailed
                                         royalty calculation sufficient to establish a statement of royalties due if any such
                                         royalties are due. Kornit will pay any royalties due together with such report. Spectra
                                         shall have the right to have the books and records of Kornit audited [***] to verify
                                         the correctness of royalty reports. If any such audit discloses an underpayment of royalties,
                                         Kornit will pay the shortfall immediately upon notice. If such shortfall exceeds [***]%
                                         of the royalties due, Kornit shall reimburse Spectra for the costs of the audit.

 

*** Confidential treatment has been requested
for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated
as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.

 

    	2

    	 

    

 

		3.	DISTRIBUTION RIGHTS

 

		3.1	Kornit may sell, lease and use
                                         Spectra Products and components thereof for Kornit Products, including, without limitation,
                                         worldwide marketing to any end user or re-marketer; provided however, that:

 

		(i)	Kornit’s distribution rights
                                         exclude Reserved Markets;

 

		(ii)	Kornit may only resell Printheads
                                         as integral components of Kornit Products, or as spare or replacement parts for Kornit
                                         Products; and

 

		(iii)	Kornit may not knowingly sell Spectra
                                         Ink or a Certified Ink for use other than in conjunction with Kornit Products.

 

To maintain the non-exclusive
rights under this Section 3.1, Kornit must fulfill its obligations under Section 2.4 at all times.

 

		3.2	To the extent Kornit may directly
                                         or indirectly market Kornit Products, Spectra Products, or other items under this Agreement,
                                         Kornit may do so under any present or future Kornit or Affiliate trademark or product
                                         designation. Kornit shall refer to any product so designated, in all Kornit sales proposals,
                                         advertising literature, and otherwise, as a Kornit or Affiliate product. Kornit may ship
                                         those products in containers bearing the Kornit or Affiliate logo, class and serial number
                                         of the product, and all other information or markings desired by Kornit or required by
                                         law; provided, however, that Kornit further agrees to affix or cease to affix, upon Spectra’s
                                         written request, a logo or identifier supplied by Spectra containing the words “Spectra
                                         Jet PoweredTM” in a mutually agreed upon location on such Kornit Products.

 

		4.	CONFIDENTIAL INFORMATION AND INTELLECTUAL PROPERTY RIGHTS

 

		4.1	In connection with the supply of
                                         Spectra Products, [***] and other activities that may be contemplated hereunder, the
                                         Parties may share their respective Confidential Information on a voluntary basis to facilitate
                                         the success and rapid time to market of Kornit Products. In order to foster a constructive
                                         and solution-oriented environment, the Parties agree to define and handle Confidential
                                         Information disclosures from and after the Effective Date and intellectual property rights
                                         in accordance with Schedule 4.

 

		4.2	The Parties agree that any agreement
                                         between them in effect as of the Effective Date covering Confidential Information will
                                         remain in full force and effect, but shall only cover disclosures made prior to the Effective
                                         Date.

 

		5.	[***]

 

		5.1	[***]

 

*** Confidential treatment has been requested
for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated
as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.

 

    	3

    	 

    

 

		6.	TERM AND TERMINATION

 

		6.1	This Agreement is effective on
                                         and after the Effective Date and shall expire 7 (seven) years after the Effective Date,
                                         unless earlier terminated pursuant to Section 6.2 below. The term will be extended by
                                         one year on each anniversary of the Effective Date unless either party notifies 90 (ninety)
                                         days prior to the anniversary of the Effective Date that it does not wish the extension
                                         to take effect.

 

		6.2	This Agreement may be terminated
                                         prior to its expiration if any of the following occur:

 

		6.2.1	Spectra and Kornit may at any time
                                         agree in writing to terminate this Agreement.

 

		6.2.2	If Kornit fails without cause to
                                         pay Spectra any amount due Spectra, Spectra may terminate this Agreement if Kornit does
                                         not cure that failure within 30 (thirty) days after Kornit receives a written notice
                                         from Spectra stating the facts on which Spectra based its determination that such a failure
                                         occurred.

 

		6.2.3	If either party breaches a material
                                         obligation of this Agreement, and such breach is not cured within 90 (ninety) days after
                                         receipt of the notice from the non-breaching party, the non-breaching party may terminate
                                         this Agreement.

 

		6.3	All financial obligations which
                                         had accrued but which were unpaid as of the effective date of termination shall survive
                                         termination. All financial obligations, which would have accrued after the effective
                                         date of termination shall terminate. All then-outstanding forecasts and purchase orders
                                         shall terminate without liability or consequence to either party as of the effective
                                         date of termination. All licenses granted hereunder shall survive termination, provided
                                         that Kornit continues to report and pay royalties required under Section 2.4.

 

		7.	MISCELLANEOUS

 

		7.1	The Parties agree to handle disputes
                                         in connection with this Agreement in accordance with Schedule 5.

 

		7.2	Spectra and Kornit are contractors
                                         independent of one another. Nothing in this Agreement is intended to or shall constitute
                                         either party as an agent, legal representative, partner, joint venture, franchisee, employee,
                                         or servant of the other for any purpose. Neither party shall make any contract, agreement,
                                         warranty, or representation on behalf of the other party, or incur any debt or other
                                         obligation in the other party’s name, or act in any manner which has the effect
                                         of making that party the apparent agent of the other; and neither party shall assume
                                         liability for, or be deemed liable as a result of, any such action by the other party.
                                         Neither party shall be liable by reason of any act or omission of the other party in
                                         the conduct of its business or for any resulting claim or judgment, including without
                                         limitation those arising from oral or written statements the other party makes in connection
                                         with its marketing efforts (other than statements made in reliance on written information
                                         which the first party furnishes to the other party).

 

*** Confidential treatment has been requested
for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated
as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.

 

    	4

    	 

    

 

		7.3	Neither Spectra nor Kornit may assign this Agreement or any of their respective rights and
                                                               obligations under this Agreement without the express written consent of the other party before that assignment, except that
                                                               either party may without the other’s prior consent assign this Agreement to a successor in ownership of all or
                                                               substantially all of its assets. Any assignment under this                                          Section 7.3 will not
                                                               relieve the assigning party of its outstanding financial obligations,                                          if any,
                                                               incurred before the assignment. This Agreement shall be binding upon and inure                                          to
                                                               the benefit of the Parties and their respective successors and permitted assigns.

 

		7.4	A waiver of a default of any term
                                         of this Agreement shall not be construed as a waiver of any later default of that provision
                                         or as a waiver of the provision itself. A party’s performance after the other party’s
                                         default shall not be construed as a waiver of that default.

 

		7.5	Each term of this Agreement is
                                         severable. If a court, agency, or arbitrator having jurisdiction determines that any
                                         term is invalid or unenforceable under applicable law, that determination shall not affect
                                         the other terms of this Agreement, which other terms shall continue to be enforced as
                                         if the invalid or unenforceable provisions were omitted.

 

		7.6	Massachusetts law shall govern
                                         the interpretation and enforcement of this Agreement, except that the Federal Arbitration
                                         Act shall govern the interpretation and enforcement of Schedule 5.

 

		7.7	Except as this Agreement otherwise
                                         provides, no amendment to this Agreement shall be binding unless agreed to in writing
                                         executed by Spectra and Kornit, and no approval, consent, or waiver shall be enforceable
                                         unless signed by the granting party. The pre-printed terms of any order (including, without
                                         limitation, a purchase order), acknowledgment, or other form do not amend this Agreement.
                                         No document shall be deemed to amend this Agreement by implication.

 

		7.8	This Agreement (including the attached
                                         Schedules, which are hereby incorporated by reference) states the complete agreement
                                         between Spectra and Kornit concerning this subject, except as stated in Section 4.2,
                                         and supersedes all earlier oral and •written communications between Spectra and
                                         Kornit concerning this subject.

 

		7.9	All notices required or permitted
                                         under this Agreement and all requests for approvals, consents, and waivers must be in
                                         writing and must be delivered by a method providing for proof of delivery to the addresses
                                         listed below:

 

*** Confidential treatment has been requested
for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated
as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.

 

    	5

    	 

    

 

In the case of Kornit:

Chief Executive Officer

Kornit Digital, Ltd.

5 David Navon Street

POB 8406

Moshav Magshimim 56910

Israel

Facsimile: +

 

	In the case of Spectra:	With a copy to:
	Chief Operating Officer	Laurel H. Finch, Attorney
	Spectra Printing	Heller Ehrman LLP
	Dimatix, Inc.	275 Middlefield Road
	109 Etna Road	Menlo Park, CA 94025-3506
	Lebanon, NH 03766-1422	Facsimile:  +1-650-324-0638
	Facsimile:  +1 603-448-9870	 

 

Any notice or request shall be
deemed to have been given on the date of receipt. Either party may change its address for the purposes of this Agreement by giving
the other party written notice of its new address.

 

		7.10	All rights granted to Kornit under
                                         this Agreement may be exercised by any Affiliate of Kornit agreeing to be bound by this
                                         Agreement.

 

AGREED TO AND ACCEPTED BY:

 

	SPECTRA PRINTING	 	KORNIT DIGITAL LTD.	 
	DIMATIX. INC.	 	 	 
	 	 	 	 
	/s/ Robert G. Rosenblum	 	/s/ Ofer Ben-Zur	 
	By:	 	By: 	 
	Robert G. Rosenblum	 	Ofer Ben-Zur	 
	 	 	Printed	 
	Chief Operating Officer	 	CEO	 
	 	 	Title:	 
	Jan. 10, 2006	 	Jan. 15, 2006	 
	Date:	 	Date:	 

 

*** Confidential treatment has been requested
for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated
as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.

 

    	6

    	 

    

 

SCHEDULE 1

 

TERMS AND CONDITIONS

 

FORECASTS AND PRODUCTION ESTIMATES:
Customer will provide Spectra with a [***], [***] forecast of Spectra Product requirements; provided, however, that orders placed
hereunder are non-cancelable and non- deferrable beginning [***] prior to scheduled delivery date. Customer will provide Spectra
with [***] advance notice to add significant additional manufacturing capacity. Spectra may not be able to meet orders as a result
of changes in or requirements in excess of those set forth in [***] forecasts. Furthermore, the Parties agree to use their reasonable
efforts, particularly during significant ramp periods, to coordinate, communicate and level out product delivery requirements
so that Customer’s requirements and Spectra’s capacity are matched as closely as possible. Production estimates are
not guaranteed, but result from careful analysis of Customer’s submitted requirements and present reasonably expected output
under normal conditions.

 

ORDERS: Customer will order Spectra
Products through the issuance of purchase orders at least [***] in advance of the requested delivery dates. All preprinted terms
and conditions on purchase orders are superseded entirely by the terms and conditions of this Agreement. Each purchase order will
adequately identify the Spectra Product ordered by use of Spectra’s product code, set forth the requested quantity, and
specify the requested delivery method and date. Purchase orders must be in writing and may be sent via e-mail or facsimile to
Spectra’s Customer Service group. To confirm its acceptance of each purchase order, Spectra will issue an acknowledgement
of such purchase order in writing or sent via e-mail or facsimile within 5 (five) business days of receipt. If Customer does not
receive an acknowledgement of a purchase order within this timeframe, Customer should contact Spectra immediately to follow up
on the status of the order.

 

Upon receipt of any purchase order submitted
in accordance with this Agreement, Spectra will either: (i) accept the order, which will establish the delivery date; or (ii)
notify Customer of Spectra’s proposed delivery date, if Spectra is unable to deliver Spectra Product in the amounts and/or
at the time or times requested. Once accepted, this will become the commitment date. If Spectra cannot fulfill Customer’s
purchase orders due to a shortage of any Spectra Product, Spectra shall use its reasonable efforts to satisfy Customer’s
purchase requirements as closely as possible.

 

PRICES: Prices are exclusive of
federal, state or excise or use taxes which will be separately shown on invoices. Prices are [***] (INCO Terms). Specification
changes by Customer may affect prices. Customer must provide Spectra with a certificate for exemption from state taxes where applicable.

 

*** Confidential treatment has been requested
for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated
as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.

 

    	1

    	 

    

 

PAYMENT AND SECURITY: Payment shall
be made by Customer within [***] of invoice date. For the purpose of securing payment of amounts due Spectra from the Customer
hereunder, Customer hereby grants to Spectra: (i) a continuing first purchase money security interest in the products to be shipped
hereunder, and all accessions thereto and substitutions therefor; and (ii) a continuing purchase money security interest in all
of the proceeds of the foregoing. If Customer fails to make payment to Spectra of any invoice for products shipped by Spectra
within [***] of the date of such invoice, or should Customer become insolvent or be a party to any bankruptcy or receivership
proceeding prior to full payment of all amounts payable hereunder, Spectra may, notwithstanding any other provisions herein set
forth, exercise any or all of its rights as a secured creditor under applicable law, including without limitation: (a) refuse
to make further shipments to Customer; (b) with or without demand or notice to Customer declare the entire amount unpaid immediately
due and payable; and (c) sell any or all of said products as permitted under applicable law, applying the proceeds of the sale
to the expenses of retaking, repairing and selling said products, reasonable attorney’s fees and to the satisfaction of
all indebtedness then due and unpaid. Any surplus shall be paid to Customer and any deficiency shall be paid to Spectra by Customer.
All past due amounts shall accrue delinquency charges at the rate of [***]% ([***] percent) per month.

 

The foregoing notwithstanding, as to orders
including any special or custom-made equipment and as to any Customer which Spectra in its sole discretion determines to have
insufficient credit worthiness, Spectra reserves the right to require all or a portion of the invoice amount in advance if commencing
work on an order, and, as the case may be, a portion upon shipment and the balance within [***] of invoice. For orders shipped
outside the United States payment may be made by bank draft (on a bank acceptable to Spectra) or by confirmed, irrevocable letter
of credit (naming Spectra as beneficiary) with order or other terms as arranged by Spectra. Any charges related to such letter
of credit or other payment arrangement shall be for Customer’s account.

 

Nothing herein shall require Spectra to
ship Spectra Products to Customer if any of the requirements in this Schedule are not fulfilled by Customer.

 

DELIVERY: Delivery to a public
carrier at Spectra’s manufacturing facility, consigned as Customer directs, shall constitute transfer of the shipment’s
title, ownership, possession, and property to Customer at point of such delivery. Carrier will thereafter be deemed as acting
for Customer and the shipment will be at Customer’s risk. Spectra Products will be delivered to Customer in packaging reasonably
acceptable to Customer, given shipment, warehousing and storage requirements. Customer will advise Spectra in writing of any special
packaging or labeling requirements at the time of placing an order. Customer will pay the cost of any special packaging.

 

WARRANTY: All Spectra Products
are warranted to be  free of defects in materials and workmanship and to  conform to Spectra specifications in effect at the
date of shipment for a period of  eighteen (18) months from date of shipment by Spectra. Any products labeled
as pre-production release or prototypes, warranty coverage will be on materials and workmanship only and for a period of
 3 months from date of shipment. Products repaired or replaced under warranty will carry coverage for the balance of warranty
period of the product from when such product was returned to Spectra.

 

During the warranty period, Spectra
will, at its option,  repair, replace or refund the purchase price of Spectra products which prove to be defective
in materials or workmanship or which do not conform to the applicable Spectra specifications. Customer must return Spectra
products to the facility designated by Spectra. Customer shall obtain a return materials authorization number
(“RMA”) and shipping instructions from Spectra, follow the proper cleaning/flushing procedures in accordance with
the respective product manual, and return the product shipping charges prepaid. Shipping charges for all agreed warranty
returns will be paid by Spectra and by Customer for all rejected warranty returns. Warranty excludes all costs of customs
clearance and any other related charges. All replaced products shall become the property of Spectra.

 

*** Confidential treatment has been requested
for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated
as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.

 

    	2

    	 

    

 

 The foregoing warranty shall not
apply to defects or non-conformance with Spectra specifications that result from:

 

		(1)	improper installation, use, storage,
                                         care or maintenance by Customer or its customers;

		(2)	modification or alteration, damage,
                                         neglect, or abuse of a Spectra product;

		(3)	operation of a Spectra product out
                                         of specification including power and environmental specifications;

		(4)	use of Inks or other chemicals not
                                         furnished or Certified by Spectra; or

		(5)	externally induced contamination (including
                                         but not limited to defective Certified Inks not supplied by Spectra and premature drying
                                         of inks in the nozzles).

 

DISCONTINUANCE: Spectra may, at
its option, discontinue Products supplied under this Agreement, provided however, that: (i) Spectra gives Customer 180 (one hundred
eighty) day notice of any planned discontinuance; and (ii) Spectra provides Customer with an end of life purchase program.

 

INFRINGEMENT OF THIRD PARTY RIGHTS:
Spectra shall promptly investigate and defend at its expense all claims that the manufacture, use, maintenance, sale or other
disposition of any Spectra Product infringes, induces the infringement of, or otherwise violates any patent, copyright, mask work,
trademark, trade secret, or proprietary or other information of any third party, and Spectra shall pay and discharge all judgments
or decrees against Customer which result from those claims. Spectra may, with Customer’s consent (which Customer shall not unreasonably withhold), settle any such
claim on terms of Spectra’s choosing, if those terms do not conflict with this Agreement; provided, however, that Spectra
shall not be obligated to the extent (i) Customer fails to give Spectra prompt notice of the claim, appropriate authority to settle
or defend it, or the information and assistance necessary to conduct the defense, or (ii) the claims of infringement arise from
or are based upon (A) Customer’s or any third party’s enhancements, modifications, alteration or implementation of
a Spectra Product, or (B) the combination of a Spectra Product with any device Spectra did not directly furnish to Customer.

 

If (i) a court, agency, or arbitrator having jurisdiction holds that, or Spectra agrees in writing with any
third party that, any Spectra Product infringes a patent, copyright, mask work, or trademark or involves an unlawful use of a third
party’s proprietary or other information, (ii) an injunction issues against Customer’s manufacturing, use, or marketing
of a Spectra Product, or (iii) in Spectra’s opinion that Spectra Product is likely to become the subject of an infringement
claim, then Spectra shall at its expense use reasonable efforts to: (x) obtain for Customer rights sufficient in scope to allow
Customer to continue to make, use, sell, and market that Spectra Product, or (y) replace or modify that Spectra Product so that
it becomes non-infringing.

 

Spectra shall not be liable under this
infringement section for any claim, and Customer’s rights under this infringement section shall not attach to a claim, to
the extent that claim is based on information, devices, or processes furnished by someone other than Spectra. Customer shall defend
and hold Spectra harmless against any expense, judgment or loss for alleged infringement or violation of any patents, copyrights,
mask works, trade secrets, trademarks, or proprietary or other information which result from Spectra’s compliance with Customer’s
designs, specifications or instructions. The foregoing states the entire obligation of Spectra with respect to infringement or
the like.

 

CANCELLATION OR RETURNS: If Spectra
agrees to the cancellation by Customer of an order within [***] of scheduled delivery, all future work thereon will be stopped
by Spectra as soon as reasonably possible and a cancellation charge will be rendered in the amount of the costs incurred to the
date of stoppage plus [***]% ([***] percent), less allowances Spectra may be able to make for standard components and salvage.
Cancellations as to any completed items shall not be effective and the order will be shipped and billed to the Customer at the
order prices.

 

*** Confidential treatment has been requested
for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated
as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.

 

    	3

    	 

    

 

SCHEDULE 2

 

PRICES FOR SPECTRA PRODUCTS

 

Prices for all Spectra Products include
standard packaging.

 

		A.	PRINTHEADS and JETTING
                                         ASSEMBLIES

 

	PART NUMBER	 	DESCRIPTION	 	ACCUMULATED

    ORDER QTY	 	 	UNIT PRICE	 

 

256-Channel Jetting Assemblies

 

	05536	 	Nova JA 256/80 AAA	 	 	 	 		 
	08991	 	Galaxy JA 256/30 AAA	 	 	 	 	 	 
	09272	 	Galaxy JA 256/50 AAA	 	 	 	 	 	 
	09493	 	Galaxy JA 256/80 AAA	 	[***] to [***]	 	$	[***]	 
	 	 	 	 	[***] to [***]	 	$	[***]	 
	 	 	 	 	[***] to [***]	 	$	[***]	 
	 	 	 	 	[***]+	 	$	[***]	 

 

	09158	 	Spectra SL-128	 	 	 	 		 
	09084	 	Spectra SM-128	 	 	 	 	 	 
	08935	 	Spectra SE-128	 	[***] to [***]	 	$	[***]	 
	 	 	 	 	[***] to [***]	 	$	[***]	 
	 	 	 	 	[***] to [***]	 	$	[***]	 
	 	 	 	 	[***]+	 	$	[***]	 

 

*** Confidential treatment has been requested
for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated
as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.

 

    	1

    	 

    

  

		B.	OTHER HARDWARE

 

	PART NUMBER	 	DESCRIPTION	 	INDIVIDUAL
 ORDER QTY	 	UNIT
 PRICE	 
	3800-038	 	Pressure Regulator	 	[***]-[***]	 	$	[***]	 
	 	 	 	 	[***]-[***]	 	$	[***]	 
	 	 	 	 	[***]+	 	$	[***]	 
	 	 	 	 	 	 	 	 	 
	08162	 	Meniscus Pressure Controller (MPC)	 	[***]-[***]	 	$	[***]	 
	 	 	 	 	[***]-[ ***]	 	$	[***]	 
	 	 	 	 	[***]+	 	$	[***]	 
	 	 	 	 	 	 	 	 	 
	06543	 	Miata Remote Lung/Reservoir	 	[***]-[ ***]	 	$	[***]	 
	 	 	 	 	[***]-[***]	 	$	[***]	 
	 	 	 	 	[***]+	 	$	[***]	 
	 	 	 	 	 	 	 	 	 
	08371	 	Molded Lung Module (MLM) 1)	 	[***]-[ ***]	 	$	[***]	 
	 	 	 	 	[***]-[ ***]	 	$	[***]	 
	 	 	 	 	[***]+	 	$	[***]	 
	05841	 	Miata Remote Lung	 	[***]	 	$	[***]	 
	 	 	 	 	 	 	 	 	 
	04649	 	HDEM-4	 	[***]-[***]	 	$	[***]	 
	 	 	 	 	[***]-[***]	 	$	[***]	 
	 	 	 	 	[***]+	 	$	[***]	 
	 	 	 	 	 	 	 	 	 
	3500-189	 	HDEM Daughter Cards	 	[***]	 	$	[***]	 
	3800-037	 	HDC2	 	[***]	 	$	[***]	 

 

*** Confidential treatment has been requested
for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated
as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.

 

    	2

    	 

    

		C.	INK PRODUCTS

 

Note: All ink prices are per order,
per color.

 

	PART NUMBER	 	DESCRIPTION	 	INDIVIDUAL
 ORDER QTY	 	UNIT
 PRICE(per
 case)	 
	00146-01	 	SABRE Black 5)	 	[***]-[***]	 	$	[***]	 
	 	 	 	 	[***]-[***]	 	$	[***]	 
	 	 	 	 	[***]+	 	$	[***]	 
	 	 	 	 	 	 	 	 	 
	See table below	 	Seurat UV Curing Ink 2)	 	[***] to [***]	 	$	[***]	 
	 	 	 	 	[***] to [***]	 	$	[***]	 
	 	 	 	 	[***] to [***]	 	$	[***]	 
	 	 	 	 	[***]+	 	$	[***]	 
	 	 	 	 	 	 	 	 	 
	See table below	 	Kappa UV Curing Ink 2)	 	[***] to [***]	 	$	[***]	 
	 	 	 	 	[***] to [***]	 	$	[***]	 
	 	 	 	 	[***] to [***]	 	$	[***]	 
	 	 	 	 	[***]+	 	$	[***]	 
	01880	 	Sirius, Ink 3)	 	[***] to [***]	 	$	[***]	 
	 	 	 	 	[***] to [***]	 	$	[***]	 
	 	 	 	 	[***] to [***]	 	$	[***]	 
	 	 	 	 	[***]+	 	$	[***]	 
	 	 	 	 	 	 	 	 	 
	01881	 	Sirius, Clear Solvent, Flush 3)	 	 	 	$	[***]	 
	 	 	 	 	 	 	 	 	 
	01882	 	Sirius, Clear, Cleaning Spray 4)	 	 	 	$	[***]	 
	 	 	 	 	 	 	 	 	 
	7060-804-93	 	7060 Model Fluid	 	[***]	 	$	[***]	 
	 	 	 	 	 	 	 	 	 
	04322	 	7060 Model Fluid	 	[***]	 	$	[***]	 
	 	 	 	 	 	 	 	 	 
	06291	 	Clear Flush	 	[***]	 	$	[***]	 

 

		1)	The pricing for these products
                                         is subject to full and final release by Spectra. No guarantee is implied as to these
                                         products ever becoming available from Spectra.

		2)	Each case contains 4 (four)
                                         1 liter bottles.

		3)	Each case contains 6 (six)
                                         1 liter bottles.

		4)	Each case contains 24 (twenty-four)
                                         125 ml bottles.

		5)	Each case
                                         contains 40 100g ink pucks.

 

PART NUMBER AND DESCRIPTION - UV
CURING INKS

 

	SEURAT RANGE
	00052	Ink,
    black
	00055	Ink, yellow
	00058	Ink, magenta
	00060	Ink, cyan
	KAPPA
    RANGE
	03604	Ink, black

 

Prices for all Spectra Products include
standard packaging.

 

		D.	VOLUME DISCOUNTS

 

Fees

		1)	Printhead Volume Discount Fee of $[***]

		2)	The Printhead Volume Discount Fee is
                                         payable to Spectra prior to Kornit shipping - or using — commercial products.

 

*** Confidential treatment has been requested
for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated
as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.

 

    	3

    	 

    

 

		3)	Upon payment of the Printhead Volume
                                         Discount Fee, Kornit will obtain the following rights:

 

	PART NUMBER	 	DESCRIPTION	 	ACCUMULATED
 ORDER QTY	 	UNIT 
 PRICE	 
	256 Channel Jetting Assemblies	 		 	[***]	 	$	[***]	 
	128 Channel Jetting Assemblies (SL, SM, SE)	 	 	 	[***]	 	$	[***]	 

 

*** Confidential treatment has been requested
for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated
as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.

  

    	4

    	 

    

 

PRICE INCREASES

 

Beginning  12 (twelve) months after
the date of this Agreement, Spectra may, by written notice delivered  90 (ninety) days in advance to Customer,
increase prices for Products listed on Schedule 2. Price increases will not apply to orders that are non-cancelable and
non-deferrable (pursuant to Schedule 1) at the time of notice of the increase.

 

Any notice of price increase in accordance
with the foregoing shall constitute an amendment to this Schedule 2.

 

*** Confidential treatment has been requested
for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated
as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.

 

    	5

    	 

    

 

ROYALTIES

 

		1)	Kornit will pay to Spectra a royalty
                                         of 5% (five percent) of the amounts received by Kornit (net of returns and allowances
                                         and sales and use taxes) upon the sale by Kornit of Ink for use in Kornit Products, except
                                         Spectra Ink.

 

		2)	If Kornit does not supply Ink to be
                                         used in Kornit Products Kornit will, in lieu of 1) above, pay to Spectra a royalty of
                                         2% (two percent) of the amounts received by Kornit (net of returns and allowances
                                         and sales and use taxes) upon the sale by Kornit of Kornit Products.

 

		3)	The first $500,000 of ink sales (on an
                                         annual basis) is not subject to the royalty provisions under section 1 above.

 

*** Confidential treatment has been requested
for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated
as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.

 

    	6

    	 

    

 

SCHEDULE
3

 

RESERVED
MARKETS: EXCLUSIVE RIGHTS RESERVED

BY SPECTRA TO OTHER CUSTOMERS

 

		I.	Product Identification

 

Exclusive Market shall
mean the following:

The market for systems
incorporating less than $[***] of Spectra supplied Printheads, where such systems are used for printing with ink on packaging,
labels or tangible products. The scope of this Reserved Market does not include

		(i)	systems used in commercial printing
                                         environments,

		(ii)	the printing of goods where the
                                         primary value of the goods is the printed content, and

		(iii)	other detailed exemptions available
                                         from Spectra upon request.

 

*(In January of each year after 2005,
the price thresholds set forth above are adjusted for inflation or deflation. The price thresholds in effect on any date can be
obtained by contacting Spectra.)

 

*** Confidential treatment has been requested
for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated
as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.

 

    	1

    	 

    

  

SCHEDULE
4

 

CONFIDENTIALITY AND

INTELLECTUAL PROPERTY RIGHTS

 

Confidentiality:

“Confidential
Information” means all information which one party (“Discloser”) discloses to the other party (“Recipient”)
during the term of this Agreement: (i) in documents or other tangible materials clearly marked “CONFIDENTIAL”; or
(ii) orally, or in any other intangible form, when first disclosed to the Recipient, if at that time the Discloser tells the Recipient
that the information is confidential and if the Discloser describes the information in writing or other tangible materials clearly
marked “CONFIDENTIAL” and delivers them to the Recipient within 30 (thirty) calendar days after the information is
first disclosed to the Recipient. “Confidential Information” does not include any information which the Recipient
can show:

		(a)	the Recipient knew at the time
                                         of disclosure;

		(b)	the public knows or which is or
                                         becomes readily ascertainable by the public, and through no wrongful act of the Recipient;

		(c)	the Recipient receives from a third
                                         party without breaching an obligation owed to the Discloser, if the third party does
                                         not restrict the Recipient from disclosing that information;

		(d)	is independently developed by or
                                         for the Recipient;

		(e)	the Discloser discloses to a third
                                         party without similar restrictions on disclosure; or

		(f)	is required to be disclosed by
                                         law, provided, however, that in the event Recipient is ordered to disclose the Discloser’s
                                         Confidential Information pursuant to a judicial or governmental request, requirement
                                         or order, Recipient shall immediately, and in any event prior to complying therewith,
                                         notify the Discloser and take reasonable steps to assist Discloser in contesting such
                                         request, requirement or order or otherwise protecting Discloser’s rights, and Recipient
                                         may not disclose any Discloser Confidential Information in response to any law, rule
                                         or regulation, including disclosure rules of the Securities and Exchange Commission,
                                         without the Discloser’s written consent in each case, which consent shall not be
                                         unreasonably withheld or delayed.

 

During the Term and
for 5 (five) years after the Term, the Recipient shall use reasonable efforts to prevent the disclosure of any Confidential Information
to any other person, subject to (f) above, and shall not analyze or reverse engineer any samples, prototypes or products labeled
“Confidential” and provided hereunder. All materials containing Confidential Information delivered by the Discloser
under this Agreement are and shall remain the property of the Discloser. At the Discloser’s written request upon termination
of the Recipient’s right to possess the Discloser’s Confidential Information, the Recipient shall promptly return
to the Discloser, or destroy and certify the destruction of, all those materials and any copies. The Recipient agrees that it
will not utilize or include any Confidential Information of Discloser in any patent or copyright filing.

 

*** Confidential treatment has been requested
for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated
as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.

 

    	1

    	 

    

 

Except as this Agreement
expressly provides, this Agreement does not: (i) restrict either party from developing new products, improving existing products,
or marketing any new, improved, or existing products; or (ii) commit either party to disclose any particular information or to
develop, make, use, buy, sell, or otherwise dispose of any existing or future product, or to favor or recommend any product or
service of the other party.

 

This Agreement does
not enlarge, diminish, or affect the rights and obligations that either party may have or come to have under any other written
agreement they both sign, or, except as this Agreement expressly provides, with respect to any patent or copyright of either party.
Except as this Agreement or such other written agreement specifically provides, there shall be no restrictions on the use or disclosure
of any information the Parties exchange at any time, in the past or in the future, other than restrictions that either party may
independently have a right to assert under the patent, copyright, or mask work laws.

 

Intellectual Property Rights:

Each party will retain
its existing intellectual property rights and nothing in this Agreement will amend that understanding. Furthermore, each party
will own all Technology developed solely by its employees, agents, representatives and consultants. In the case that a joint invention
by employees, agents, representatives or consultants of Customer and Spectra is made in connection with Agreement, then both Parties
will own an equal interest in such Technology and any patents which issue as a result. In the event that one party is granted
a patent which incorporates Confidential Information of the other party, that one party will grant upon request a paid up, worldwide
right and license under such patent to the other party to make, have made, use and sell products of the other party.

 

*** Confidential treatment has been requested
for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated
as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.

 

    	2

    	 

    

 

SCHEDULE
5

 

DISPUTES

 

In the event of any
dispute, controversy or claim between the Parties arising directly or indirectly under this Agreement, whether based on contract,
tort, fraud, misrepresentation or other legal theory, the Parties shall attempt in good faith to resolve such matter through mediation.
Such mediation shall be conducted in accordance with The CPR Mediation Procedure of the CPR Institute for Dispute Resolution in
effect on the date of this Agreement. If either party refuses to engage in such mediation, or if such mediation has not resolved
the dispute, controversy or claim within [***], or such longer period as the Parties may agree, then the provisions below shall
apply.

 

Except for disputes
concerning Spectra’s indemnification obligations regarding infringement of third party rights, and except as otherwise
provided in this Agreement, Customer and Spectra shall settle by arbitration any controversy or claim between them arising
directly or indirectly under this Agreement, whether based on contract, tort, fraud, misrepresentation, or other legal theory
that is not resolved through mediation as provided in the paragraph above. The arbitration shall occur in Massachusetts,
under the then current Rules for Non-Administered Arbitration and supervision of the CPR Institute for Dispute Resolution,
except as otherwise provided herein. If the dispute involves a claim for money in the amount of $[***] ([***] dollars) or
less and does not involve any claims relating to ownership, use, or disclosure of intellectual property (other than a claim
of unlawful ownership, use or disclosure of intellectual property arising solely from a failure to pay a license fee or
royalty), the arbitration shall be before a single arbitrator whom Customer and Spectra shall select from a panel of persons
knowledgeable in business information and data processing systems; otherwise, the arbitration shall be before
three arbitrators, one selected by Customer, one selected by Spectra, and the third selected by the two arbitrators selected.
The arbitrator or arbitrators shall not have the power to award punitive or exemplary damages. The decision and award of
the arbitrator or arbitrators shall be final and binding and the award rendered may be entered in any court having
jurisdiction. Customer and Spectra shall each pay its own attorney’s fees associated with the arbitration, and shall
pay the other costs and expenses of the arbitration as the rules of the American Arbitration Association provide.

 

Spectra and Customer
may each petition a court of law for injunctive relief to protect its respective intellectual property.

 

If one party files a
court action alleging claims subject to binding arbitration under this Schedule and the other party successfully stays the court
action or compels arbitration of the claims, or both, the party filing the court action shall pay the other party’s costs
and expenses, including attorneys’ fees, of obtaining such stay or compulsion.

 

Neither Customer nor
Spectra may bring any action, regardless of form, related to this Agreement, more than two years after the cause of action accrues.

 

*** Confidential treatment has been requested
for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated
as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.

 

    	1

    	 

    

 

The duty to arbitrate
extends to any director, officer, employee, agent, subsidiary, or Affiliate making or defending any claim which would otherwise
be arbitrable.

 

Each part of this Schedule is severable.
A holding that any part of this Schedule is unenforceable shall not affect the duty to arbitrate under any part of this Schedule.

 

*** Confidential treatment has been requested
for redacted portions of this exhibit. This copy omits the information subject to the confidentiality request. Omissions are designated
as [***]. A complete version of this exhibit has been provided separately to the Securities and Exchange Commission.

 

    	2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}]]